NGL Fine-Chem (NSE:NGLFINE) Marketable Securities: ₹432 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NGLFINE NGL Fine-Chem Ltd NSE:NGLFINE
78 GF Score
Price ₹3,280.00
GF Value ₹2,855.32
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is NGL Fine-Chem Marketable Securities?

NGL Fine-Chem NSE:NGLFINE +0.88% 78 Marketable Securities is ₹432 Mil as of Mar. 2026. GuruFocus rates NSE:NGLFINE with a GF Score™ of 78/100 and a GF Value™ of ₹2,855.32 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. NGL Fine-Chem's Marketable Securities for the quarter that ended in Mar. 2026 was ₹432 Mil.

NGL Fine-Chem's annual Marketable Securities increased from Mar. 2024 (₹559 Mil) to Mar. 2025 (₹659 Mil) but then declined from Mar. 2025 (₹659 Mil) to Mar. 2026 (₹432 Mil).

NGL Fine-Chem  (NSE:NGLFINE) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

NGL Fine-Chem Marketable Securities Related Terms

NGL Fine-Chem Marketable Securities Historical Data

* Premium members only.

The historical data trend for NGL Fine-Chem's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NGL Fine-Chem Marketable Securities Chart

NGL Fine-Chem Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 298.68 449.92 558.95 659.31 432.15

NGL Fine-Chem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 659.31 0.00 618.27 0.00 432.15
NSE:NGLFINE
78GF Score
NGL Fine-Chem Ltd NSE:NGLFINE
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NGL Fine-Chem Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹432 Mil mean?
NGL Fine-Chem (NSE:NGLFINE) has a Marketable Securities of ₹432 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on NGL Fine-Chem and its competitors.
Is NGL Fine-Chem's Marketable Securities too high?
NGL Fine-Chem's current Marketable Securities is ₹432 Mil. Overall, NGL Fine-Chem has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NGL Fine-Chem's Marketable Securities compare to LLY and JNJ?
NGL Fine-Chem's Marketable Securities of ₹432 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on NGL Fine-Chem and its competitors. NGL Fine-Chem's current Marketable Securities is ₹432 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NGL Fine-Chem stock overvalued right now?
Based on GuruFocus' analysis, NGL Fine-Chem (NSE:NGLFINE) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,855.32, compared to a current price of ₹3,280.00 — trading 14.9% above its estimated fair value. The current Marketable Securities is ₹432 Mil. NGL Fine-Chem's overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For NGL Fine-Chem (NSE:NGLFINE), the current Marketable Securities is ₹432 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NGL Fine-Chem (NSE:NGLFINE) Overvalued in 2026?

Based on GuruFocus' analysis, NGL Fine-Chem stock appears to be overvalued. The current stock price of ₹3,280.00 is trading 14.9% above its estimated GF Value™ of ₹2,855.32. GuruFocus considers NGL Fine-Chem to be Modestly Overvalued.

Key valuation signals for NSE:NGLFINE:

  • Marketable Securities: ₹432 Mil
  • GF Value™: ₹2,855.32 vs. price of ₹3,280.00 (14.9% above fair value)
  • GF Score™: 78/100 with 8 warning signs

No single metric tells the full story. See the NSE:NGLFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NGL Fine-Chem Business Description

Other Exchanges 524774:India
Address 301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
78GF Score

Get the complete analysis for NSE:NGLFINE

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,280.00
Price
₹2,855.32
GF Value